A process for discriminating between biological states based on hidden patterns from biological data

Details for Australian Patent Application No. 2008201163 (hide)

Owner The United States of America, as represented by the Department of Health and Human Services Correlogic Systems, Inc

Inventors Petricoin III, Emanuel F; Levine, Peter J; Hitt, Ben A; Liotta, Lance A

Agent Pizzeys

Pub. Number AU-A-2008201163

Parent 2001280581

Filing date 11 March 2008

Wipo publication date 3 April 2008

International Classifications

G01N 27/62 (2006.01) Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means - by investigating the ionisation of gases

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

3 April 2008 Application Open to Public Inspection

  Published as AU-A-2008201163

3 April 2008 Complete Application Filed

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201164-Smart water timer

2008201162-Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphavbeta3 antagonists in combination with other prophylactic or therapeutic agents